| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 4.40e-05 | 51 | 27 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 1.09e-04 | 69 | 27 | 3 | GO:0045309 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.40e-04 | 229 | 27 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 5.18e-04 | 117 | 27 | 3 | GO:0051219 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 7.99e-04 | 31 | 27 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 8.52e-04 | 32 | 27 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.61e-03 | 44 | 27 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.76e-03 | 46 | 27 | 2 | GO:0004715 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.22e-03 | 194 | 27 | 3 | GO:0016705 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.35e-03 | 709 | 27 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 2.87e-03 | 59 | 27 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | kinase activity | 3.24e-03 | 764 | 27 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.47e-03 | 65 | 27 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 6.55e-03 | 90 | 27 | 2 | GO:0030971 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 7.71e-03 | 938 | 27 | 5 | GO:0016772 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 7.73e-03 | 98 | 27 | 2 | GO:0051213 | |
| GeneOntologyMolecularFunction | protein kinase activity | 8.18e-03 | 600 | 27 | 4 | GO:0004672 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 9.28e-03 | 324 | 27 | 3 | GO:0005126 | |
| HumanPheno | Nephrotic syndrome | 1.74e-05 | 139 | 7 | 4 | HP:0000100 | |
| HumanPheno | Abnormal renal cortex morphology | 1.79e-05 | 320 | 7 | 5 | HP:0011035 | |
| HumanPheno | Glomerulopathy | 4.06e-05 | 172 | 7 | 4 | HP:0100820 | |
| HumanPheno | Abnormal eosinophil morphology | 9.10e-05 | 72 | 7 | 3 | HP:0001879 | |
| HumanPheno | Pleural effusion | 1.83e-04 | 91 | 7 | 3 | HP:0002202 | |
| HumanPheno | Abnormal renal glomerulus morphology | 2.86e-04 | 283 | 7 | 4 | HP:0000095 | |
| HumanPheno | Abnormal renal corpuscle morphology | 2.86e-04 | 283 | 7 | 4 | HP:0031263 | |
| HumanPheno | Glomerulonephritis | 3.31e-04 | 111 | 7 | 3 | HP:0000099 | |
| HumanPheno | Inflammation of the large intestine | 4.06e-04 | 119 | 7 | 3 | HP:0002037 | |
| Domain | SH2 | 2.09e-05 | 110 | 28 | 4 | SM00252 | |
| Domain | SH2 | 2.17e-05 | 111 | 28 | 4 | PS50001 | |
| Domain | SH2 | 2.25e-05 | 112 | 28 | 4 | IPR000980 | |
| Domain | - | 2.25e-05 | 112 | 28 | 4 | 3.30.505.10 | |
| Domain | GAIN_dom_N | 1.18e-04 | 11 | 28 | 2 | IPR032471 | |
| Domain | GAIN | 1.18e-04 | 11 | 28 | 2 | PF16489 | |
| Domain | Kringle | 2.91e-04 | 17 | 28 | 2 | IPR000001 | |
| Domain | Kringle | 2.91e-04 | 17 | 28 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 2.91e-04 | 17 | 28 | 2 | PS00021 | |
| Domain | Kringle_CS | 2.91e-04 | 17 | 28 | 2 | IPR018056 | |
| Domain | KR | 2.91e-04 | 17 | 28 | 2 | SM00130 | |
| Domain | KRINGLE_2 | 2.91e-04 | 17 | 28 | 2 | PS50070 | |
| Domain | FA58C | 4.47e-04 | 21 | 28 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.47e-04 | 21 | 28 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.47e-04 | 21 | 28 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.47e-04 | 21 | 28 | 2 | PS01286 | |
| Domain | SH2 | 4.56e-04 | 101 | 28 | 3 | PF00017 | |
| Domain | F5_F8_type_C | 5.86e-04 | 24 | 28 | 2 | PF00754 | |
| Domain | FA58C | 5.86e-04 | 24 | 28 | 2 | IPR000421 | |
| Domain | HormR | 6.36e-04 | 25 | 28 | 2 | SM00008 | |
| Domain | HRM | 8.00e-04 | 28 | 28 | 2 | PF02793 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.05e-03 | 32 | 28 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.05e-03 | 32 | 28 | 2 | PS51406 | |
| Domain | Kringle-like | 1.05e-03 | 32 | 28 | 2 | IPR013806 | |
| Domain | FIBRINOGEN_C_1 | 1.05e-03 | 32 | 28 | 2 | PS00514 | |
| Domain | GPS | 1.18e-03 | 34 | 28 | 2 | SM00303 | |
| Domain | GPS | 1.25e-03 | 35 | 28 | 2 | PF01825 | |
| Domain | GPS | 1.32e-03 | 36 | 28 | 2 | PS50221 | |
| Domain | GPS | 1.40e-03 | 37 | 28 | 2 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 1.47e-03 | 38 | 28 | 2 | PS50025 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.63e-03 | 40 | 28 | 2 | PS00649 | |
| Domain | Laminin_G_2 | 1.63e-03 | 40 | 28 | 2 | PF02210 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.63e-03 | 40 | 28 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 1.63e-03 | 40 | 28 | 2 | IPR001879 | |
| Domain | LamG | 1.97e-03 | 44 | 28 | 2 | SM00282 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.54e-03 | 50 | 28 | 2 | PS00650 | |
| Domain | 7tm_2 | 2.54e-03 | 50 | 28 | 2 | PF00002 | |
| Domain | - | 2.77e-03 | 663 | 28 | 5 | 2.60.40.10 | |
| Domain | IG | 3.39e-03 | 421 | 28 | 4 | SM00409 | |
| Domain | Ig_sub | 3.39e-03 | 421 | 28 | 4 | IPR003599 | |
| Domain | Laminin_G | 3.40e-03 | 58 | 28 | 2 | IPR001791 | |
| Domain | Ig-like_fold | 3.63e-03 | 706 | 28 | 5 | IPR013783 | |
| Domain | GPCR_2-like | 3.64e-03 | 60 | 28 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 3.64e-03 | 60 | 28 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.76e-03 | 61 | 28 | 2 | PS50261 | |
| Domain | EGF | 5.11e-03 | 235 | 28 | 3 | SM00181 | |
| Domain | IG_LIKE | 5.86e-03 | 491 | 28 | 4 | PS50835 | |
| Domain | EGF-like_dom | 6.00e-03 | 249 | 28 | 3 | IPR000742 | |
| Domain | Ig-like_dom | 6.37e-03 | 503 | 28 | 4 | IPR007110 | |
| Domain | TyrKc | 7.66e-03 | 88 | 28 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.66e-03 | 88 | 28 | 2 | IPR020635 | |
| Domain | Galactose-bd-like | 8.70e-03 | 94 | 28 | 2 | IPR008979 | |
| Domain | PROTEIN_KINASE_TYR | 9.24e-03 | 97 | 28 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.24e-03 | 97 | 28 | 2 | IPR008266 | |
| Pathway | WP_PDGF_PATHWAY | 2.72e-05 | 40 | 21 | 3 | M39555 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 3.15e-05 | 42 | 21 | 3 | MM1504 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 3.63e-05 | 44 | 21 | 3 | M19784 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 6.73e-05 | 54 | 21 | 3 | M39435 | |
| Pathway | WP_PROLACTIN_SIGNALING | 1.87e-04 | 76 | 21 | 3 | M39601 | |
| Pathway | REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS | 2.84e-04 | 17 | 21 | 2 | M27612 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.56e-04 | 19 | 21 | 2 | M47733 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE | 5.25e-04 | 23 | 21 | 2 | M39843 | |
| Pathway | REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING | 5.72e-04 | 24 | 21 | 2 | M27604 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.00e-04 | 113 | 21 | 3 | MM14783 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.81e-04 | 118 | 21 | 3 | M713 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 7.25e-04 | 27 | 21 | 2 | M1909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 7.25e-04 | 27 | 21 | 2 | M47906 | |
| Pathway | WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING | 7.81e-04 | 28 | 21 | 2 | M39632 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 7.81e-04 | 28 | 21 | 2 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 7.81e-04 | 28 | 21 | 2 | M2529 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 8.38e-04 | 29 | 21 | 2 | MM1452 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M39616 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.05e-03 | 137 | 21 | 3 | M5669 | |
| Pubmed | 1.33e-07 | 13 | 28 | 3 | 15688026 | ||
| Pubmed | 2.11e-07 | 15 | 28 | 3 | 10790433 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31150793 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29995830 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26807827 | ||
| Pubmed | The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. | 6.25e-07 | 2 | 28 | 2 | 7798261 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 8.19e-07 | 90 | 28 | 4 | 16273093 | |
| Pubmed | IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. | 1.87e-06 | 3 | 28 | 2 | 31305264 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10867021 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 9620604 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20846526 | ||
| Pubmed | T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase. | 3.75e-06 | 4 | 28 | 2 | 11005864 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20641039 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 7760813 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 21344162 | ||
| Pubmed | Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. | 6.24e-06 | 5 | 28 | 2 | 19018007 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 16339550 | ||
| Pubmed | Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. | 6.24e-06 | 5 | 28 | 2 | 10662792 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 8570203 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 8530437 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 9.36e-06 | 6 | 28 | 2 | 34143959 | |
| Pubmed | Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. | 9.36e-06 | 6 | 28 | 2 | 16467851 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 10964907 | ||
| Pubmed | SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome. | 1.31e-05 | 7 | 28 | 2 | 15456882 | |
| Pubmed | Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. | 1.31e-05 | 7 | 28 | 2 | 10646608 | |
| Pubmed | When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer. | 1.31e-05 | 7 | 28 | 2 | 35417234 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 9047237 | ||
| Pubmed | Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells. | 1.31e-05 | 7 | 28 | 2 | 12084069 | |
| Pubmed | Sequential phosphorylation of SLP-76 at tyrosine 173 is required for activation of T and mast cells. | 1.31e-05 | 7 | 28 | 2 | 21725281 | |
| Pubmed | Phosphorylation of the linker for activation of T-cells by Itk promotes recruitment of Vav. | 1.31e-05 | 7 | 28 | 2 | 12186560 | |
| Pubmed | Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. | 1.74e-05 | 8 | 28 | 2 | 11390470 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 11368773 | ||
| Pubmed | The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. | 1.74e-05 | 8 | 28 | 2 | 11133830 | |
| Pubmed | Identification of substrates of human protein-tyrosine phosphatase PTPN22. | 2.24e-05 | 9 | 28 | 2 | 16461343 | |
| Pubmed | LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. | 2.24e-05 | 9 | 28 | 2 | 9489702 | |
| Pubmed | 2.25e-05 | 1116 | 28 | 7 | 31753913 | ||
| Pubmed | 2.80e-05 | 73 | 28 | 3 | 24728074 | ||
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 26936881 | ||
| Pubmed | 3.28e-05 | 77 | 28 | 3 | 22973453 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 22732588 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 20598684 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 9269777 | ||
| Pubmed | 4.73e-05 | 87 | 28 | 3 | 29991678 | ||
| Pubmed | p190RhoGAP Filters Competing Signals to Resolve Axon Guidance Conflicts. | 5.65e-05 | 14 | 28 | 2 | 30902550 | |
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 26389685 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.43e-04 | 22 | 28 | 2 | 26494785 | |
| Pubmed | 1.71e-04 | 24 | 28 | 2 | 20624904 | ||
| Pubmed | Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef. | 2.17e-04 | 27 | 28 | 2 | 22844345 | |
| Pubmed | 2.17e-04 | 27 | 28 | 2 | 19604093 | ||
| Pubmed | 2.33e-04 | 28 | 28 | 2 | 18067320 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 2.50e-04 | 29 | 28 | 2 | 15203201 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 2.50e-04 | 29 | 28 | 2 | 31491374 | |
| Pubmed | 3.05e-04 | 32 | 28 | 2 | 22974441 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 3.25e-04 | 33 | 28 | 2 | 25713288 | |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 4.61e-04 | 824 | 28 | 5 | 20237496 | |
| Pubmed | 6.33e-04 | 46 | 28 | 2 | 23793062 | ||
| Pubmed | 6.33e-04 | 46 | 28 | 2 | 30419336 | ||
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 7.18e-04 | 49 | 28 | 2 | 15588985 | |
| Pubmed | 7.78e-04 | 51 | 28 | 2 | 26764350 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 7.78e-04 | 925 | 28 | 5 | 28986522 | |
| Interaction | CD5 interactions | 9.51e-06 | 30 | 28 | 3 | int:CD5 | |
| Interaction | PTK2B interactions | 2.12e-05 | 119 | 28 | 4 | int:PTK2B | |
| Interaction | ABL1 interactions | 2.60e-05 | 259 | 28 | 5 | int:ABL1 | |
| Interaction | PLCG1 interactions | 2.85e-05 | 264 | 28 | 5 | int:PLCG1 | |
| Interaction | BTK interactions | 4.60e-05 | 145 | 28 | 4 | int:BTK | |
| Interaction | CD247 interactions | 6.00e-05 | 55 | 28 | 3 | int:CD247 | |
| Interaction | PAG1 interactions | 1.08e-04 | 67 | 28 | 3 | int:PAG1 | |
| Interaction | PTPRC interactions | 1.18e-04 | 69 | 28 | 3 | int:PTPRC | |
| Interaction | IL6ST interactions | 1.46e-04 | 74 | 28 | 3 | int:IL6ST | |
| Interaction | PDGFRA interactions | 1.70e-04 | 385 | 28 | 5 | int:PDGFRA | |
| Interaction | NR0B2 interactions | 2.05e-04 | 83 | 28 | 3 | int:NR0B2 | |
| Interaction | SHB interactions | 2.12e-04 | 84 | 28 | 3 | int:SHB | |
| Interaction | ZAP70 interactions | 2.78e-04 | 92 | 28 | 3 | int:ZAP70 | |
| GeneFamily | SH2 domain containing | 8.99e-05 | 101 | 16 | 3 | 741 | |
| GeneFamily | Immunoglobulin like domain containing | 6.05e-04 | 193 | 16 | 3 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.66e-03 | 394 | 16 | 3 | 471 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.40e-02 | 206 | 16 | 2 | 682 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.25e-07 | 193 | 28 | 5 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-07 | 199 | 28 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-06 | 153 | 28 | 4 | d8773ee16c7d3e0834b9f64054d42336d6f9833b | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 155 | 28 | 4 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 155 | 28 | 4 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-06 | 157 | 28 | 4 | 34eb1cbdb023d3e23b2e1695c9c327c21ef1c870 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-06 | 157 | 28 | 4 | fc0c222124f59c94d60335f849554eaa4062f8c7 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-06 | 157 | 28 | 4 | 40b08ace1d9ea7951886f5fed76ac57e9175436b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 159 | 28 | 4 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 159 | 28 | 4 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 161 | 28 | 4 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 161 | 28 | 4 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 162 | 28 | 4 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 162 | 28 | 4 | 4b490989005bb03d4e7bbea01580f8548eff150f | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 162 | 28 | 4 | e4a09bf1a51710f6c57e6e01edf8b4619459d96d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 163 | 28 | 4 | a0315855c354e830e109d41bd6e3396488aa8de9 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 163 | 28 | 4 | 801163c05f8fdacaebd0cb9b4c92741276bfa3e3 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 163 | 28 | 4 | e58863a462cc504bced627f004a47890ee2307ce | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-06 | 164 | 28 | 4 | c2cd4e4b88cc1b80a9494f59d31339007ff824c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-06 | 164 | 28 | 4 | 649e42d9cfdec2f7771d1e938b516e46e7d07078 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-06 | 164 | 28 | 4 | ba85f7b21ae34e285d286ada24715885ca6329f7 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-06 | 164 | 28 | 4 | d4d08353c7322f97ea07dd583b08661d635fff20 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-06 | 165 | 28 | 4 | 88745bf7ecb0f7fc93077cea20171d40535dd56b | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-06 | 167 | 28 | 4 | cde82e3dacf347226a78873b166608b7851b34d4 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-06 | 167 | 28 | 4 | 6f54a699d9266c5f09ed890a11b403a6c8476fc1 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-06 | 167 | 28 | 4 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | Immune_cells-NK_cells|Immune_cells / Lineage and Cell class | 3.58e-06 | 168 | 28 | 4 | 125d70c37eb49eb4d1f503bb8d536b225254c7cb | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 170 | 28 | 4 | 71e5e27c3c4e6cc8dc9b063bd51c21c049f54416 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 170 | 28 | 4 | 255bbbd00d0e17510c5a8c5faa43ed90d887a9de | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.84e-06 | 171 | 28 | 4 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 172 | 28 | 4 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 172 | 28 | 4 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 172 | 28 | 4 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 174 | 28 | 4 | 6863222bec844f40c0c80f5c82a8ff51d1a56d0a | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 174 | 28 | 4 | d570eab215f8287362084e37f35672e20aa0f7a2 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 174 | 28 | 4 | 5739c1b8d643ad360ef32049832d749c530ca603 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 179 | 28 | 4 | 874a9afa91774221c9c1775aa4968ba0aea7b554 | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.71e-06 | 180 | 28 | 4 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 180 | 28 | 4 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 180 | 28 | 4 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.24e-06 | 185 | 28 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-06 | 186 | 28 | 4 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.36e-06 | 186 | 28 | 4 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-06 | 187 | 28 | 4 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.47e-06 | 187 | 28 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.59e-06 | 188 | 28 | 4 | a29c43a91ed1364a09d5abab6efa51b8061bce74 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.59e-06 | 188 | 28 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.59e-06 | 188 | 28 | 4 | 0a2be6eac6fde669fbc58fd1b2e93e4acf17ddde | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-06 | 189 | 28 | 4 | 5a9c3c61998efc40a5d2042e0f568b52103734a9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.71e-06 | 189 | 28 | 4 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.71e-06 | 189 | 28 | 4 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.83e-06 | 190 | 28 | 4 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.83e-06 | 190 | 28 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.83e-06 | 190 | 28 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-06 | 191 | 28 | 4 | 753deb090b7b78b4ef31604dbe5dbfc4dcf5184a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-06 | 191 | 28 | 4 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-06 | 191 | 28 | 4 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.07e-06 | 192 | 28 | 4 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 6.20e-06 | 193 | 28 | 4 | e325cf49e159c6be205ed93adaa09efdd0c122b4 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.20e-06 | 193 | 28 | 4 | 91a1c9b8390cbd881db8c49d8f34feca0d1067d6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 6.20e-06 | 193 | 28 | 4 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-NK|Bac-SEP / Disease, Lineage and Cell Type | 6.20e-06 | 193 | 28 | 4 | 8aa4ed2b11c6189d86e7de6bc68782fd156a37fb | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 6.20e-06 | 193 | 28 | 4 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 6.20e-06 | 193 | 28 | 4 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-06 | 194 | 28 | 4 | 5a859885c0f9b8554b0d203e371c70928ad4418f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-06 | 194 | 28 | 4 | 6b5be379074241973220f7ef02ef3d5d7d8428ef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-06 | 194 | 28 | 4 | 7d35ac70ba966eb1fee4197f7de6d6116326a442 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-06 | 194 | 28 | 4 | f6a655e1c2be2a326b934db0a5268e4db9112a74 | |
| ToppCell | ILEUM-inflamed-(6)_ILC1|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.33e-06 | 194 | 28 | 4 | dc9ca407ec3ebec1a3dea1213a2beef28c1dc043 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 6.33e-06 | 194 | 28 | 4 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-06 | 194 | 28 | 4 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 194 | 28 | 4 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 6.33e-06 | 194 | 28 | 4 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-06 | 194 | 28 | 4 | 4b3f400a5b7b8f999016e2daba50f65f4535b529 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-06 | 194 | 28 | 4 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 6.33e-06 | 194 | 28 | 4 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-06 | 195 | 28 | 4 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 6.46e-06 | 195 | 28 | 4 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-06 | 195 | 28 | 4 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-06 | 195 | 28 | 4 | acc603dc94ac6518adb0dffb43305b380ec75b52 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 6.46e-06 | 195 | 28 | 4 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 195 | 28 | 4 | 7533822d2fe551f499b5b2fdec7172f56c79cb44 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 6.46e-06 | 195 | 28 | 4 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 195 | 28 | 4 | a868aadca4a81cfeb773a18b0daad1ea5ece8fa8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-06 | 195 | 28 | 4 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 6.46e-06 | 195 | 28 | 4 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 6.46e-06 | 195 | 28 | 4 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | normal-na-Lymphocytic_NK|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-06 | 195 | 28 | 4 | cebe79c42af5910353ba9ad7d0edb01982f772a3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 196 | 28 | 4 | 8e1ed30256a031bb90dac1f167e074c68efbed74 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 6.59e-06 | 196 | 28 | 4 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 196 | 28 | 4 | 61bc0d161e01f36e5bcda4d4f4693afbfe5654bb | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.59e-06 | 196 | 28 | 4 | bd251231288c900b23d3a676ceec6ac07d228917 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.59e-06 | 196 | 28 | 4 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class | 6.59e-06 | 196 | 28 | 4 | cc1daf12de5765ba4f7002396352404b41df2012 | |
| ToppCell | tumor_Lung-T/NK_cells-NK|tumor_Lung / Location, Cell class and cell subclass | 6.59e-06 | 196 | 28 | 4 | 006e630f3d8033f45c6b7e9154d77000c7b0cb70 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 196 | 28 | 4 | f424c45be7f34cbef76e1696dea10c1e3a9af2e0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 196 | 28 | 4 | c25f90c4e5abfe7cfaa85bfe136c438a5179c978 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 196 | 28 | 4 | 9bb87d20c25df0dc8e48bcb32b57f81a3dc1c0cd | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 196 | 28 | 4 | d451f279f4086fcf727af712f98923551181c76e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-06 | 196 | 28 | 4 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.25e-05 | 8 | 27 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 9.49e-05 | 265 | 27 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 9.62e-05 | 266 | 27 | 4 | C0242379 | |
| Disease | hepatitis C (is_marker_for) | 4.71e-04 | 35 | 27 | 2 | DOID:1883 (is_marker_for) | |
| Disease | Hepatitis, Toxic | 4.73e-04 | 404 | 27 | 4 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 4.73e-04 | 404 | 27 | 4 | C4279912 | |
| Disease | Drug-Induced Liver Disease | 4.73e-04 | 404 | 27 | 4 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 4.73e-04 | 404 | 27 | 4 | C3658290 | |
| Disease | Chemical and Drug Induced Liver Injury | 4.73e-04 | 404 | 27 | 4 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 4.73e-04 | 404 | 27 | 4 | C1262760 | |
| Disease | hepatocyte growth factor-like protein measurement | 5.55e-04 | 38 | 27 | 2 | EFO_0008154 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.67e-04 | 206 | 27 | 3 | C0152013 | |
| Disease | parental longevity | 1.00e-03 | 494 | 27 | 4 | EFO_0007796 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 1.87e-03 | 70 | 27 | 2 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | hypothyroidism | 2.17e-03 | 284 | 27 | 3 | EFO_0004705 | |
| Disease | multisite chronic pain | 3.42e-03 | 95 | 27 | 2 | EFO_0010100 | |
| Disease | estradiol measurement | 4.55e-03 | 110 | 27 | 2 | EFO_0004697 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRRFRMCQATGTQGY | 496 | O60241 | |
| GRIGMRIEVYGCAYK | 166 | Q9BZ76 | |
| MCYQISRGNSDGYII | 1421 | O95490 | |
| LEVARYMVQRGGCVY | 731 | Q96KQ7 | |
| LQDAGVYRCMISYGG | 106 | Q9NZQ7 | |
| RIIAMCGDYYIGGRR | 231 | P20936 | |
| YISSRMAGGGQKVCY | 51 | P43351 | |
| QICKGMDYLGSRQYV | 986 | P23458 | |
| GIKYIGMRNEQAACY | 51 | Q9UJ83 | |
| RMAGQYSCIYRVGEL | 91 | O76036 | |
| QSRGQYSCSGQVMYI | 76 | Q6DN72 | |
| YGLYCMQSGGINIRI | 171 | O14986 | |
| CRMKGYQLAGVEAGY | 156 | Q8NCW0 | |
| GGFGCVYRAVMRNTV | 221 | P51617 | |
| GCAVYQDMIYAVGGR | 501 | Q9Y2M5 | |
| VRVTVPGNYYQLMCG | 3776 | Q9Y6R7 | |
| YGANRIYAGQMAVLG | 61 | Q99807 | |
| GQRATLSGIYRYIMG | 36 | O43638 | |
| YVRTCIMNNGVGYRG | 106 | P26927 | |
| GRIGMRIEVYGCAYK | 166 | Q96NU0 | |
| LYGCRNQGYQLLRSM | 701 | P42702 | |
| NRTYCCGTYRAGPMR | 461 | Q5VWQ0 | |
| GAYNPMCTYVNRGRR | 136 | Q13275 | |
| GLLYQGLMNGVRFYC | 76 | Q6PIV7 | |
| GAVNMCYRTLYIGTG | 806 | Q96QT6 | |
| CGNFGSVRQGVYRMR | 346 | P43403 | |
| ACQMLLRGTFYQGYR | 531 | P15498 | |
| SRGMYYGRDVNVCRC | 91 | Q8IUF8 |